Home - Gastroenterology Advisor
Colonoscopy Prep and Other Quality Indicators for CRC Screening From ACG/ASGE. The American College of Gastroenterology and the American Society for Gastrointestinal Endoscopy Quality Task force have released updated guidance on quality indicators for colonoscopy.
Clinician Insights on How to Manage Semaglutide-Induced …
Sep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
Sep 1, 2023 · There were no reports of gastroparesis in the study. 1. While semaglutide and other GLP-1 agonists cause adverse events, such as nausea, vomiting, diarrhea, and a range of other GI symptoms, these effects of delayed gastric emptying are reported to be reduced after 20 weeks of use. 2. [T]here are some cases where gastroparesis may resolve if ...
Gastroparesis Awareness Month: Updated Guidelines to Treat …
Aug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
FDA Alert: Gastroenterology Drug Approvals and New Indications
Sep 27, 2024 · FDA New Indications. Voquezna® (vonoprazan): Heartburn Associated With Nonerosive GERD. On July 18, 2024, the FDA approved vonoprazan for the relief of heartburn associated with nonerosive GERD in adults. 5. Medication Class: potassium-competitive acid blocker 6. Dosing: Relief of heartburn with nonerosive GERD in adults: 10 mg once daily for ...
2021 American College of Gastroenterology Guidelines: Upper ...
Jun 2, 2021 · The American College of Gastroenterology (ACG) released clinical guidelines on upper gastrointestinal (GI) and ulcer bleeding using an evidence-based approach, which was recently published in The American Journal of Gastroenterology.. The researchers used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology to develop 16 clinical recommendations for the ...
Vyloy Approved for Gastric and Gastroesophageal Junction Cancer
Nov 6, 2024 · Vyloy is a chimeric IgG1 monoclonal antibody that binds to CLDN18.2 on the cancer cell surface of gastric epithelial cells. This action results in antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The approval is based on data from the phase 3 GLOW (ClinicalTrials.gov Identifier: NCT03653507) and SPOTLIGHT ...
2021 American College of Gastroenterology Guidelines: Prevention ...
Aug 25, 2021 · The American College of Gastroenterology (ACG) released updated clinical guidelines on the prevention, diagnosis, and treatment of Clostridioides difficile infections (CDI), which was recently published in The American Journal of Gastroenterology.These guidelines represent the official practice recommendations of the ACG and indicate the preferred approach to the management of adults with CDI.
Chronic Idiopathic Constipation: 10 Recommendations for …
Jun 9, 2023 · The American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) have jointly developed a clinical practice guideline regarding the pharmacological management of patients with chronic idiopathic constipation (CIC), as published in the American Journal of Gastroenterology and Gastroenterology.. The guideline provides 10 evidence-based recommendations for ...
Novel Drug Tradipitant Effective, Safe for Treatment of Nausea in ...
Oct 29, 2021 · Tradipitant appears to be an effective and safe treatment option for gastroparesis symptoms, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held from October 22 to 27, 2021, in Las Vegas, Nevada and virtually.